Date: June 30, 2020
Hosted by: brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium on Neurodegeneration in Aging (CCNA).
Presented by: Julie Robillard, PhD, Assistant Professor of Neurology; Scientist, Patient Experience, The University of British Columbia, BC Children's & Women's Hospitals & Eric Edward Smith, MD, MPH, FRCPC, FAHA, Professor of Neurology Katthy Taylor Chair in Vascular Dementia, Cumming School of Medicine, University of Calgary.
Summary:
The COVID-19 pandemic has disproportionately affected older persons with comorbidities, with a high fatality rate in this group.
In this webinar, we review the basics of SARS-CoV-2 (the virus that causes COVID-19); what is known so far about its effects on the body and on the brain; and on outcomes when infection occurs in persons living with dementia. We discuss the ethics of allocating scarce medical resources during a pandemic, and the effects it may have on access to care for persons with dementia.
This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium on Neurodegeneration in Aging (CCNA).
